Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Jul 26, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how chronic kidney disease (CKD) develops in people with metabolic diseases like high blood pressure, diabetes, obesity, and high uric acid levels. Researchers want to understand the common factors that lead to kidney damage in these patients and find ways to diagnose and treat the condition early. They believe that different metabolic diseases may affect the kidneys in similar ways, leading to damage over time.

To be eligible for this study, participants should be between 18 and 80 years old and have been diagnosed with a metabolic disease. They must be able to understand the study and agree to take part by signing a consent form. However, people with certain kidney diseases or other serious health issues will not be included. If you participate, you can expect to be part of a group that helps researchers learn more about kidney health and potentially improve future treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The diagnosis of metabolic diseases were confirmed;
• • Be able to understand the process of the research;
• • Volunteer for participation and be able to sign the informed consent.
• Exclusion Criteria:
• • Age \<18 yrs or \>80yrs;
• • Patients with primary and secondary glomerular diseases
• • Patients with other comorbidities that could affect the volume or the components of the kidney, such as renal cysts, polycystic kidney disease, medullary sponge kidney, hydronephrosis, renal artery stenosis, renal vein thrombosis and/or renal tumors;
• • Contraindications for MRI examination;
• • Pregnant or lactation patients;
• • Patients with unstable vital signs, failure of other organs or dysphoria.